Summit Partners Research
Investment Thesis
Summit Partners is a leading growth-focused alternative investment firm founded in 1984 in Boston, Massachusetts. With over $44 billion in assets under management and a 41+ year track record spanning more than 550 portfolio companies, Summit aims to be the investment partner of choice for category-leading companies and exceptional executive talent. Their core mission is "Powering Profitable Growth" — grounded in a foundational belief that profitable growth is the most reliable path to building a durable business and creating long-term value.
Summit is widely credited as a pioneer of growth equity investing, occupying the space between early-stage venture capital and traditional leveraged buyout private equity. They partner with companies that have demonstrated product-market fit and meaningful revenue, backing them with capital ranging from $10 million to $500 million per investment, as both minority and majority shareholders. The firm is explicitly founder-friendly (Inc. Founder Friendly Investors 2025) and adapts investment structure to the company's needs.
Sector Focus
Summit invests exclusively in three macro sectors:
Technology
- Enterprise software and SaaS
- Developer tools and infrastructure, including AI/ML infrastructure
- Cybersecurity and trust infrastructure
- Marketing technology and advertising technology
- Vertical software platforms
- Fintech and financial software
Healthcare & Life Sciences
- Digital health and healthcare IT
- Healthcare services and care delivery
- Medical technology and devices
- Biotech and life sciences services
- Clinical research organizations
Growth Products & Services
- Financial services and wealth management
- Consumer brands and products
- Business services
- Industrial technology
- Logistics and supply chain
Stage Focus
Summit focuses on growth-stage companies — businesses with established products, meaningful revenue, and a demonstrated path to profitability. This typically corresponds to Series B through pre-IPO stages. Minimum stated investment is $10 million; the typical single-company check ranges from $50M to $300M, with the stated ceiling at $500 million. Summit's stated investment range is $10M-$500M per company.
Check Size
$10 million to $500 million per investment. Summit can serve as the sole institutional capital provider or invest alongside other growth equity firms. The firm can structure both minority and majority investments depending on company needs.
Lead Tendency
Summit typically leads growth equity rounds as the primary capital partner, taking active board seats and providing deep operational support through the Peak Performance Group. They have invested as both minority and majority shareholders across their 41-year history.
Recent Activity
Summit is actively deploying from its most recent flagship growth equity fund. In June 2024, the firm was reported to be targeting $9 billion for its 12th flagship growth equity fund. Key investments in 2025-2026 include:
- Keyfactor (July 2026): $1B+ strategic growth investment in PKI and trust infrastructure for the AI and post-quantum era, co-invested with Insight Partners and Sixth Street
- Quantifind (June 2026): $200M growth investment in AI-native risk intelligence platform for financial crime detection
- Runpod (June 2026): $100M in AI developer cloud infrastructure
- HyperLight (June 2026): $80M Series C in photonic integrated circuits for AI infrastructure
- Manychat (April 2025): Marketing automation and customer conversation platform
- Instrumentl (April 2025): Grant discovery and management platform for nonprofits
- RIS Rx (June 2025): Real-time gross-to-net revenue protection solutions for pharma
Notable exits in 2025-2026:
- Doctrine (April 2026): RELX Group announced agreement to acquire this French legal intelligence platform
- Dreampath Diagnostics (2026): Acquired by Halma PLC after Summit investment in July 2025
- Dr. Squatch: Acquired by Unilever
- Klaviyo: IPO on NYSE under ticker KVYO
- Darktrace: IPO on London Stock Exchange
Portfolio Highlights
Summit has backed over 550 companies since inception with 175+ public offerings and 250+ strategic sales or mergers. Since 2021 alone, Summit portfolio companies have completed 900+ acquisitions and 200+ capital markets transactions. Notable current portfolio companies include:
- Keyfactor — PKI and machine identity management for AI/quantum era
- Keeper Security — Zero-trust, zero-knowledge cybersecurity platform
- StackAdapt — Programmatic advertising platform
- Manychat — Marketing automation and customer conversation platform
- Jobber — Field service management software for home service businesses
- FNZ — Global wealth management platform
- Optimove — Marketing automation and customer data platform
- MUBI — Global independent film subscription platform
- TradingHub — Trade surveillance technology for global financial institutions
- Runpod — AI Developer Cloud infrastructure
- VaxCare — Care delivery platform for vaccines
- StackAdapt — Self-serve programmatic advertising platform
Historic notable investments and exits include Klaviyo (IPO: KVYO), Darktrace (IPO: DARK.L), FleetCor Technologies (IPO: FLT), BluePearl Veterinary Partners (acquired by Mars), Healthline Media (acquired by Red Ventures), and over 250 other M&A exits.
Team
Summit Partners employs 225+ professionals across five global offices. The investment team consists of sector-specialized Managing Directors and Partners:
Leadership
- Peter Y. Chung — Managing Director & CEO, Technology focus (Menlo Park)
- Scott C. Collins — Managing Director & COO, Technology focus (Boston)
- Adam H. Hennessey — Managing Director & CFO (Boston)
Technology Managing Directors & Partners
- Leonard C. Ferrington — Managing Director, Technology (Boston)
- Michael A. Medici — Managing Director, Technology (Boston)
- Andrew J. Collins — Managing Director, Technology (Menlo Park)
- Colin T. Mistele — Managing Director, Technology (Menlo Park)
- Antony C. Clavel — Managing Director, Technology (London)
- Matthias G. Allgaier — Managing Director, Technology (London)
- Steffan K. Peyer — Managing Director, Technology (London)
- Scott R. Ferguson — Partner, Technology (Menlo Park)
- Nick Oppedisano — Partner, Technology (Menlo Park)
- Sophia Popova — Partner, Technology (Boston)
Healthcare & Life Sciences Managing Directors & Partners
- Darren M. Black — Managing Director, Healthcare & Life Sciences (Boston)
- Craig D. Frances, M.D. — Managing Director, Healthcare & Life Sciences (Menlo Park)
- Peter A. Francis — Managing Director, Healthcare & Life Sciences (Boston)
- Jono Pagden — Partner, Healthcare & Life Sciences (London)
Growth Products & Services Managing Directors & Partners
- John R. Carroll — Managing Director, Growth Products & Services (Boston)
- Christopher Dean — Managing Director, Growth Products & Services (Boston)
- Matthew G. Hamilton — Managing Director, Growth Products & Services (Boston)
- Johannes N. Grefe — Managing Director, Growth Products & Services (London)
- Paul G. Furer — Partner, Growth Products & Services (Boston)
- Ricardo Gonzalez — Partner, Growth Products & Services (Boston)
- Chris Bon — Partner, Growth Products & Services (London)
Decision Process
Summit Partners operates as a full investment partnership with a formal investment committee. Deals are sourced and championed by sector-focused Managing Directors and Partners with deep domain expertise; they then go through partnership review and investment committee approval. This structure has enabled disciplined decision-making across the firm's global offices for over 41 years. Summit is known for taking a collaborative approach: deal teams engage deeply with management teams over months before investment.
Founder & Operator Preferences
Summit favors category-leading companies with proven products, meaningful ARR or revenue, and a clear path to market dominance. They partner with experienced operators and executive teams with entrepreneurial drive, competitive intensity, and a bias for profitable growth. Summit explicitly values "toughness and tenacity" and the willingness to work hard. They are named to Inc.'s Founder Friendly Investors list and will structure minority or majority deals based on what best serves the company.
Geographic Focus
Summit has a global footprint with five offices:
- Boston, MA — Headquarters, largest office
- Menlo Park, CA — Major US West Coast presence
- New York, NY
- London, UK — European hub
- Luxembourg — European operations
They invest globally with primary focus on North America and Europe. They have a particularly deep track record in UK and European technology and healthcare companies.
Value Creation: Peak Performance Group
Summit's Peak Performance Group (PPG) is a dedicated team of operational specialists who provide free, on-demand support to portfolio companies across:
- Revenue optimization and growth marketing
- Price optimization and the office of the CFO
- M&A execution — 900+ portfolio company acquisitions completed since 2021
- Human capital and senior executive recruiting
- Technology and data science
- Capital markets transactions — 200+ completed since 2021
This operational capability is a key differentiator for Summit versus traditional financial buyers. The PPG covers revenue, marketing, M&A, talent, technology, and capital markets — a comprehensive operational overlay at no cost to the portfolio company.